Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction

Background/Aims: Qiliqiangxin (QL), a traditional Chinese medicine, has been demonstrated to be effective and safe for the treatment of chronic heart failure. Left ventricular (LV) remodeling causes depressed cardiac performance and is an independent determinant of morbidity and mortality after myoc...

Full description

Bibliographic Details
Published in:Cellular Physiology and Biochemistry
Main Authors: Anbang Han, Yingdong Lu, Qi Zheng, Jian Zhang, YiZhou Zhao, Mingjing Zhao, Xiangning Cui
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2018-02-01
Subjects:
Cardiac remodeling
Qiliqiangxin
Myocardial infarction rat
TGF-β1/Smad3
NF-κB
Online Access:https://www.karger.com/Article/FullText/487871

Internet

https://www.karger.com/Article/FullText/487871

Similar Items